Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by PBaelishhon Jul 28, 2023 5:13pm
118 Views
Post# 35562406

RE:RE:RE:RE:RE:Excellent result from Johnson & Johnson

RE:RE:RE:RE:RE:Excellent result from Johnson & JohnsonI can't imagine either but it is not a stretch... Gagnon's role for the past 11 years - PRIORITY 1, 2 AND 3 - for him as CEO was to imagine losing Symrise AND mitigate the associated risk, NOT to increase it.

All Gagnon has done is paint himself and shareholders into a smaller and smaller corner every year.

Press releases are nothing more than obfuscation and Gagnon telling himself he is a legend... in his own mind.

I hope I am wrong, really.

It's just numbers are such a nag as through analysis, they speak for themselves.
<< Previous
Bullboard Posts
Next >>